Peaches Biotech
Founding Year: 2008
Industries: biotechnology
Business Model: manufacturing
Income Stream: selling own inventory
Business Focus: B2B
Short Description (in English): Peaches Biotech group advances health science and technology to benefit society.
Overview (in English): Peaches Biotech Group focuses on developing advanced therapies and technologies in health and biotechnology. They collaborate with research groups, including a bioincubator at the Fuenlabrada University Hospital. The team includes President Ignacio Vega, Dr. Juan Pedro Lapuente as Scientific Director, and CEO Juan Carlos de Gregorio, with expertise in pharmaceuticals, biotechnology, and healthcare.
See profile on the Startup Radar madri+d platform on Dealroom:
News and Interviews
- Jun 25, 2025 RWK Bidco AB completes the recommended cash offer to the shareholders of Biotage AB and becomes the owner of 93.12 percent of…
- Mar 19, 2025 Biotech secures £600,000 for '3D lung' to replace animal testing
- Oct 22, 2024 Biotech secures £9m to expand collagen-based biomaterial for the fashion industry
- Abr 15, 2024 Renewable energy company launches spin out to boost biofuel production
- Jul 16, 2023 PSC Biotech welcomes Lori Kim as Vice President of Global Technical Operations
- Jul 11, 2023 Biotech raises $174M in hong kong IPO to race in ADC market
- Jun 08, 2023 Sabinsa Wins 2023 Technology Innovation Award in China for LactoSpore
- Jun 05, 2023 Oral Biolife Announces the Appointment of Bill Breitenbach as Chief Executive Officer | Healthcare Industry Today
- May 16, 2023 tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat …
- Nov 14, 2022 ACE® Announces New Language Support
- Sep 23, 2022 HCVC invests into Biotech in $2.6M
- Ago 02, 2022 Biotech partners with Pharmaceutical Tech
- May 10, 2022 Aegasislabs partners with Biotech
- Mar 22, 2022 Biotech partners with Actionable Insights
- Mar 08, 2022 Coalition for Epidemic Preparedness Innovations partners with Cambridge Enterprise
- Feb 09, 2022 Greenhill Manor partners with PSC Biotech
- Ene 12, 2022 Genflow identified as competitor of PSC Biotech on Jan 12th 22'.
- Ene 07, 2022 PSC Biotech partners with Baystreet
- Ene 07, 2022 PSC Biotech partners with Phoenix Venture Partners LLC
- Ene 06, 2022 PSC Biotech promoted Justin Jay to Chief Operating Officer on Dec 10th 21'.
- Dic 30, 2021 Data Career partners with PSC Biotech
- Sep 20, 2021 PSC Biotech receives award Judge’s Choice at Startup Day 2020
- Jul 09, 2021 PSC Biotech partners with BioSpace, Inc.
- Jul 09, 2021 PSC Biotech partners with Arterial Capital Management
- Jul 09, 2021 CerraCap is developing protein-based drugs
- Jun 30, 2021 PSC Biotech partners with Cormorllp
- Jun 14, 2021 AbSci Announces Acquisition of Target Discovery Company Totient
- Jun 14, 2021 PSC Biotech partners with AbSci
- Jun 13, 2021 PSC Biotech partners with Helicaseventure
- Abr 24, 2018 PSC Biotech sold assets to Laboratory Solutions of New England Inc. on Apr 1st 18'.